Stocktoria

GOLDENWELL BIOTECH, INC. GWLL

OTC · stock · Food and Kindred Products · website · IPO 2021-12-07

GOLDENWELL BIOTECH, INC. financials (annual)

Revenue
$0 $0 $15967 $47800 $2340 $139 $55 2019202020212022202320242025
Net income
-$2311 -$6324 -$116981 -$985097 -$117361 -$131498 -$296471 2019202020212022202320242025
Free cash flow
2019202020212022202320242025

Bars are annual figures from 2019 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue$55$139$2,340$47,800$15,967$0$0
Gross profit$12$64$666$25,186$8,388$0$0
SG&A expense————$126,655$6,368$2,601
Operating income-$113,326-$123,098-$115,826-$985,105-$118,267——
Interest expense$8,400$8,400$1,535—$0$0$0
Income tax$0$0$0$0$0$0$0
Net income-$296,471-$131,498-$117,361-$985,097-$116,981-$6,324-$2,311
EPS (diluted)$0.00$0.00$0.00————
Operating cash flow-$22,629-$123,077-$113,153-$1.1M-$205,138-$6,324-$2,311
Cash & equivalents——$53,231$45,996$213,556$248,569$246,593
Inventory$174,745$174,788$174,863$176,058$198,671$0—
Total assets$36,120$224,192$228,094$248,400$460,979$248,569$246,593
Total liabilities$379,833$271,433$143,837$46,782$159,266$0$0
Shareholders' equity-$343,713-$47,241$84,257$201,618$301,713$248,569$246,593

Growth · year-over-year

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue growth-60.4%-94.1%-95.1%+199.4%———

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2024-12-31. Facts plus Stocktoria's own computed scores — not investment advice.